Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

The Smokerface poster campaign for adolescent smoking prevention in schools: A cluster-randomized controlled trial.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Integration and validation of complementary ex vivo assays for functional precision oncology.

NPJ precision oncology·2026

Same author

A pooled analysis of phase 2 clinical trials in advanced chordoma.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.

Blood·2026

Same author

Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretion.

Scientific reports·2026

Same author

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Med (New York, N.Y.)·2026

Search research articles

相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

让我们变得功能化吧:药物敏感性分析,以实现精确的肉瘤药物.

Claudia R Ball¹, Stefan Fröhling²

¹Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT/University Cancer Center Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), Dresden, Germany; Faculty of Biology, Dresden University of Technology (TUD), Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.

|October 4, 2024

概括

来自患者瘤的短期培养可以选多种药物来检测骨和软组织肉瘤. 这一进步为高风险癌症患者提供了个性化的治疗选择.

更多相关视频

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关实验视频

Last Updated: Jun 11, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

科学领域:

在瘤学瘤学.
翻译医学是一种翻译医学.
癌症治疗方法癌症治疗方法

背景情况:

在患者衍生瘤模型中对药物敏感性分析对于治疗选择有限的癌症至关重要.
骨和软组织瘤代表高危恶性瘤,往往缺乏有效的治疗策略.

研究的目的:

评估骨和软组织肉瘤的短期培养对药物敏感性概况的有用性.
确定这种方法是否能够对药物和药物组合进行临床上有意义的查.

主要方法:

从患者获得的骨和软组织肉瘤样本建立短期培养.
在这些培养物中选多种单剂药物和药物组合的抗癌活性.

主要成果:

短期培养成功促进了药物敏感性分析.
该方法允许对各种治疗剂和组合进行临床相关的查.

结论:

短期瘤培养是一种可行的和有效的工具,用于查骨和软组织瘤的药物敏感性.
这种方法代表了针对这些具有挑战性的疾病的个性化癌症护理的重大进展.